Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice.
Matthieu LilamandJosué CleryAgathe VrillonFrançois Mouton-LigerEmmanuel CognatSinead GaubertClaire HourregueMatthieu MartinetJulien DumurgierJacques HugonElodie Bouaziz-AmarClaire PaquetPublished in: International journal of molecular sciences (2022)
CSF Alpha-synuclein evaluation could help to early differentiate patients with DLB and AD in association with existing biomarkers.